Clinical trial
A Prospective, Randomized, Multicenter Study to Demonstrate the Superiority of…
NCT01283438 · Intrinsic Therapeutics, Industry · Unknown status
Key facts
| NCT number | NCT01283438 |
|---|---|
| Title | A Prospective, Randomized, Multicenter Study to Demonstrate the Superiority of the Barricaid to Discectomy for Primary Lumbar Disc Herniation |
| Official title | A Prospective, Randomized, Multicenter Study to Demonstrate the Superiority of the Barricaid® to Discectomy for Primary Lumbar Disc Herniation: Extended Follow-Up of the Barricaid® Annular Closure Device (ACD) Randomized Control Trial (RCT) Postmarket Cohort for Lumbar Disc Herniation and… |
| Lead sponsor | Intrinsic Therapeutics, Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Lumbar Disc Herniation |
| Intervention type | Device |
| Interventions | Barricaid, Standard of Care |
| Enrollment | 554 |
| Start date | Dec 17, 2010 |
| Primary completion | Oct 1, 2016 |
| Completion | Jun 1, 2025 |
| First posted | Jan 26, 2011 |
| Last update posted | Sep 28, 2023 |
| Countries | Austria, Belgium, France, Germany, Netherlands, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: